Absence is not neutral.
Regulatory modernization, AI integration, and global competition ae reshaping drug development in real time The leaders setting those expectations will be at DIA 2026 Global Annual Meeting. And your organization should be there too.
Download this read-to-send justification letter to get your attendance approved quickly, with a professional case already built for you.
This letter covers:
- Strategic rationale - regulatory, AI, and competitive landscape framing
- What's new in 2026 - reimagined format, plenary sessions, LIFT Series
- Who attends - FDA, PMDA, MHRA, EU regulators and global pharma leaders
- Investment summary - fillable placeholders for registration, travel, and lodging
- A compelling close your manager won't forget
